Stemline Therapeutics, Inc. (Nasdaq: STML), a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing innovative oncology therapeutics, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Stemline Therapeutics (STML) Prices 8.89M Share Upsized Common Offering at $9/ShJanuary 16, 2019 6:12 AM Stemline Therapeutics Announces Proposed Public Offering of Common StockJanuary 14, 2019 4:34 PM